These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5109429)

  • 1. Methylphenidate hallucinosis.
    Lucas AR; Weiss M
    JAMA; 1971 Aug; 217(8):1079-81. PubMed ID: 5109429
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of hallucination from methylphenidate in an 8-year-old hyperkinetic boy].
    Albert E; Mouren MC; Dugas M
    J Toxicol Clin Exp; 1985; 5(3):195-9. PubMed ID: 3880287
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action.
    Young JG
    J Dev Behav Pediatr; 1981 Jun; 2(2):35-8. PubMed ID: 7263866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate-induced visual hallucinations.
    Porfirio MC; Giana G; Giovinazzo S; Curatolo P
    Neuropediatrics; 2011 Feb; 42(1):30-1. PubMed ID: 21500140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hallucinations caused by the introduction of methylphenidate at low doses].
    Aguilera-Albesa S; Yoldi-Petri ME; Molins-Castiella T; Durá-Travé T
    Rev Neurol; 2010 Aug; 51(4):254-5. PubMed ID: 20648469
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: The hyperactive child.
    Minde KK
    Can Med Assoc J; 1975 Jan; 112(2):130-1. PubMed ID: 1111863
    [No Abstract]   [Full Text] [Related]  

  • 7. Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7-year old girl.
    Goetz M; Prihodova I; Hrdlicka M
    Neuro Endocrinol Lett; 2011; 32(5):619-22. PubMed ID: 22167138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate induction of complex visual hallucinations.
    Halevy A; Shuper A
    J Child Neurol; 2009 Aug; 24(8):1005-7. PubMed ID: 19502578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication for hyperkinetic children.
    Pediatrics; 1975 Apr; 55(4):560-2. PubMed ID: 1128965
    [No Abstract]   [Full Text] [Related]  

  • 10. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate.
    Quinn PO; Rapoport JL
    Am J Psychiatry; 1975 Mar; 132(3):241-5. PubMed ID: 1090193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate and the hyperkinetic state.
    Fischer KC; Wilson WP
    Dis Nerv Syst; 1971 Oct; 32(10):695-8. PubMed ID: 5291582
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: convulsions and ritalin?
    Chamberlain RW
    Pediatrics; 1974 Nov; 54(5):658-9. PubMed ID: 4453480
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylphenidate (ritalin) and other drugs for treatment of hyperactive children.
    Med Lett Drugs Ther; 1977 Jul; 19(13):53-5. PubMed ID: 865414
    [No Abstract]   [Full Text] [Related]  

  • 14. Dextroamphetamine and methylphenidate in the treatment of hyperactive-aggressive children.
    Winsberg BG; Press M; Bialer I; Kupietz S
    Pediatrics; 1974 Feb; 53(2):236-41. PubMed ID: 4590730
    [No Abstract]   [Full Text] [Related]  

  • 15. The growth of children given stimulant drugs.
    Nutr Rev; 1973 Mar; 31(3):91-2. PubMed ID: 4574834
    [No Abstract]   [Full Text] [Related]  

  • 16. [Visual hallucinations caused by methylphenidate].
    Tomás Vila M; Izquierdo Quevedo FJ; Cerdán Vera MT; Fernández A; Artés Figueres M; Revert Gomas M
    An Pediatr (Barc); 2010 Mar; 72(3):229-30. PubMed ID: 20097145
    [No Abstract]   [Full Text] [Related]  

  • 17. Depression of growth in hyperactive children on stimulant drugs.
    Safer D; Allen R; Barr E
    N Engl J Med; 1972 Aug; 287(5):217-20. PubMed ID: 4556640
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonproprietary name and trademarks of drug.
    AvRuskin TW; Lala V; Tang SC; Juan CS
    Am J Dis Child; 1979 May; 133(5):553-5. PubMed ID: 433881
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children.
    Safer DJ; Allen RP
    Pediatrics; 1973 Apr; 51(4):660-7. PubMed ID: 4697515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.